|
1
|
Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease.
|
Ann Intern Med
|
2007
|
3.13
|
|
2
|
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.
|
Arterioscler Thromb Vasc Biol
|
2005
|
1.43
|
|
3
|
LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures.
|
J Lipid Res
|
2006
|
1.42
|
|
4
|
Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).
|
Circulation
|
2005
|
1.34
|
|
5
|
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.13
|
|
6
|
Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association.
|
Circulation
|
2015
|
1.08
|
|
7
|
Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome.
|
Metabolism
|
2004
|
1.01
|
|
8
|
Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.96
|
|
9
|
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
|
Metabolism
|
2005
|
0.95
|
|
10
|
Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women.
|
Arterioscler Thromb Vasc Biol
|
2005
|
0.92
|
|
11
|
TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
|
Arterioscler Thromb Vasc Biol
|
2005
|
0.91
|
|
12
|
Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women.
|
Am J Cardiol
|
2008
|
0.91
|
|
13
|
Influence of the DASH diet and other low-fat, high-carbohydrate diets on blood pressure.
|
Curr Atheroscler Rep
|
2005
|
0.88
|
|
14
|
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
|
Atherosclerosis
|
2002
|
0.88
|
|
15
|
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.
|
J Lipid Res
|
2007
|
0.86
|
|
16
|
Treating to target: implementing an effective diabetes care paradigm for managed care.
|
Am J Manag Care
|
2010
|
0.84
|
|
17
|
Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects.
|
J Lipid Res
|
2012
|
0.79
|
|
18
|
Atorvastatin and cardiovascular risk in the elderly--patient considerations.
|
Clin Interv Aging
|
2008
|
0.79
|
|
19
|
Comparison of coronary plaque subtypes in male and female patients using 320-row MDCTA.
|
Atherosclerosis
|
2012
|
0.77
|
|
20
|
Lipoprotein metabolism in subjects with hepatic lipase deficiency.
|
Metabolism
|
2004
|
0.76
|
|
21
|
Stable isotopes in obesity research.
|
Mass Spectrom Rev
|
2005
|
0.75
|
|
22
|
Complete resolution of a mitral valve vegetation with anticoagulation in seronegative antiphospholipid syndrome.
|
Clin Rheumatol
|
2008
|
0.75
|